sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Asia Pacific Ocular Drug Delivery Market...

亚太地区眼部药物输送市场预测至 2028 年 - COVID-19 影响和区域技术分析（植入式眼部药物输送系统、颗粒药物输送系统、纳米颗粒药物输送系统等）、制剂类型（脂质体和纳米颗粒、解决方案） 、乳剂、混悬剂和软膏）、疾病类型（青光眼、糖尿病视网膜病变、干眼综合症、黄斑变性、白内障、糖尿病黄斑水肿等）和最终用户（医院、眼科诊所和门诊手术中心）

TIPRE00025781 | Pages: 145 | Pharmaceuticals | Nov 2021 | Type: Regional | Status: Published

市场介绍

亚太地区由中国、日本、印度、澳大利亚和韩国五个主要国家组成。还对亚太地区其他国家的市场进行了评估。日本在亚太地区眼部给药市场中占有最大份额。在日本，正常眼压性青光眼（NTG）（青光眼的一种形式）的发病率大幅增加或更高。青光眼的患病率主要见于老年人群；截至 2017 年，日本有近 400 万人登记患有青光眼。该国改进了青光眼治疗方案。这一改进为全国各地的患者引入了新的抗青光眼眼科解决方案和微创青光眼手术。同样，该国也有相当数量的干眼病（DED）患者，该国针对干眼病进行了各种研究。研究结果显示，日本人中DED的患病率相对较高。该国每位患者的年度健康计划费用估计接近 323 美元。此外，该国糖尿病患者数量不断增加，这是糖尿病视网膜病变的另一个主要原因。在日本总人口中，约 720 万成年人患有糖尿病，占近 7.7%。该国面临着眼科医生数量不断减少的问题。然而，就医疗基础设施的发展而言，该国是重要国家之一。

2019 年新型冠状病毒（2019-nCoV）被世界卫生组织正式命名为 COVID-19，已传播到超过包括中国在内的 170 个国家促使世界卫生组织宣布该疾病为全球大流行病。 COVID-19 对整个亚太地区的眼保健服务产生了巨大影响。在孟加拉国，所有常规选择性眼科手术均被推迟。仅在门诊进行紧急眼科治疗。此外，只有在紧急情况下才允许患者去医院。同样，在印度，外展眼保健服务大部分停止，从而影响了农村社区。所有择期手术均被推迟。糖尿病视网膜病变和青光眼等非白内障患者因随访中断而受到影响。此外，COVID-19 对马尔代夫的眼保健产生了巨大影响。由于封锁，人们无法从一个地方前往另一个地方。空运和海运均处于停滞状态，离岛民众无法前往最近的眼科护理中心。首都马累的一些中心正在为患者提供在线咨询。然而，这有其局限性，医疗保健专业人员无法在线进行验光，也无法进行详细的眼前节和后节检查。因此，COVID 19 对马尔代夫眼科护理的质量和数量产生了重大影响。

市场概况和动态

亚太地区眼科给药市场预计将从 2021 年的 32.3493 亿美元增长到 2028 年的 56.0856 亿美元。预计 2021 年至 2028 年该市场的复合年增长率为 8.2%。白内障、青光眼、年龄相关性黄斑变性、糖尿病性视网膜病变和未解决的屈光不正是失明或低视力的主要原因。大多数人一生中都患有或患有某种眼部疾病。根据世界卫生组织 (WHO) 2021 年 2 月发布的报告《失明和视力障碍》，全球约有 22 亿人存在近视力或远视力障碍。据估计，视力丧失或低视力的主要原因是白内障（9400万）和未矫正的屈光不正（8840万）。此外，视力丧失的其他常见原因包括青光眼（770 万）、角膜混浊（420 万）、糖尿病性视网膜病变（390 万）和沙眼（200 万）。因此，眼部疾病的迅速流行可能会促进市场的增长。

主要细分市场

亚洲太平洋眼部药物输送市场根据技术、制剂类型、疾病类型、最终用户进行细分。按技术划分，2021年植入式眼部给药系统份额最高。按剂型划分，2021年溶液细分市场份额最高。按疾病类型划分，2021年白内障细分市场份额最高。终端用户医院细分市场在 2021 年占据最高份额。

主要来源和上市公司

一些主要的初级和准备本亚太地区眼部药物输送市场报告时参考的二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有艾伯维公司（AbbVie Inc.）；博士健康公司；诺华公司； Clearside 生物医学公司；和台湾脂质体股份有限公司等等。

购买原因报告

  • 通过确定亚太眼部药物输送市场的增长、规模、领先参与者和细分市场，节省和减少进行入门级研究的时间
  • 强调关键业务优先事项，以帮助公司重新调整业务战略
  • 主要调查结果和建议强调了亚太眼部药物输送市场的重要进步行业趋势，从而使整个价值链的参与者能够发展有效的长期战略
  • 利用发达市场和新兴市场的大幅增长来制定/修改业务扩张计划
  • 深入审查亚太市场趋势和前景以及驱动因素眼部药物输送市场以及阻碍该市场的因素
  • 通过了解支持客户产品、细分、定价和分销方面商业利益的策略，加强决策过程

亚太眼部给药市场细分

 

亚太眼部药物输送市场 –按技术划分

  • 植入式眼部药物输送系统
  • 颗粒药物输送系统
  • 纳米粒子给药系统
  • 其他

< span>亚太眼部给药市场 –按配方类型

  • 溶液
  • 软膏
  • 悬浮液
  • 乳液
  • 脂质体和纳米颗粒
< br />

亚太眼部药物输送市场 –按疾病类型

  • 白内障
  • 干眼症
  • 黄斑变性
  • 青光眼
  • 糖尿病视网膜病变
  • 糖尿病性黄斑水肿
  • 其他

亚太地区 span> 眼部药物输送市场 –按最终用户

  • 医院
  • 眼科诊所
  • 门诊手术中心

亚太眼部药物输送市场 –按国家/地区

  • 日本
  • 中国
  • 印度
  • 韩国
  • 澳大利亚
  • 休息亚太地区

亚太眼部药物输送市场 –提及的公司

  • AbbVie Inc.                               ;        
  • 博士健康公司有限公司          
  • 诺华制药公司              ;                  &n公共服务提供商; 
  • Clearside 生物医学公司;     
  • 台湾脂质体股份有限公司

TABLE OF CONTENTS

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Asia Pacific Ocular Drug Delivery Market – By Technology

1.3.2        Asia Pacific Ocular Drug Delivery Market – By Formulation Type

1.3.3        Asia Pacific Ocular Drug Delivery Market – By Disease Type

1.3.4        Asia Pacific Ocular Drug Delivery Market – By End User

1.3.5        Asia Pacific Ocular Drug Delivery Market – By Country

2.          Asia Pacific Ocular Drug Delivery Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Asia Pacific Ocular Drug Delivery – Market Landscape

4.1        Overview

4.2        Expert Opinions

5.          Asia Pacific Ocular Drug Delivery Market– Key Market Dynamics

5.1        Market Drivers

5.1.1        Burgeoning Prevalence of Eye Disorders

5.1.2        Accelerated Research on Ocular Drug Delivery

5.2        Market Restraints

5.2.1        Difficulties Associated with Ocular Drug Delivery

5.3        Market Opportunities

5.3.1        Boosting Awareness About Vision Care

5.4        Future Trends

5.4.1        Rise of Innovative Products

5.5        Impact analysis

6.          Asia Pacific Ocular Drug Delivery – Market Analysis

6.1        Asia Pacific Ocular Drug Delivery Market Revenue Forecast and Analysis

7.          Asia Pacific Ocular Drug Delivery Market Analysis – By Technology

7.1        Overview

7.2        Asia Pacific Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

7.3        Implantable Ocular Drug Delivery Systems

7.3.1        Overview

7.3.2        Implantable Ocular Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.4        Particulate Drug Delivery Systems

7.4.1        Overview

7.4.2        Particulate Drug Delivery Systems Market Revenue and Forecast to 2028 (US$ Million)

7.5        Nano-Particle Drug Delivery System

7.5.1        Overview

7.5.2        Nano-Particle Drug Delivery System Market Revenue and Forecast to 2028 (US$ Million)

7.6        Others

7.6.1        Overview

7.6.2        Others Market Revenue and Forecast to 2028 (US$ Million)

8.          Asia Pacific Ocular Drug Delivery Market Analysis – By Formulation Type

8.1        Overview

8.1.1        Asia Pacific Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

8.2        Liposomes and Nanoparticles Market

8.2.1        Overview

8.2.2        Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

8.3        Solution

8.3.1        Overview

8.3.2        Solution Market Revenue and Forecasts to 2028 (US$ Million)

8.4        Emulsion

8.4.1        Overview

8.4.2        Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

8.5        Suspension

8.5.1        Overview

8.5.2        Suspension Market Revenue and Forecasts to 2028 (US$ Million)

8.6        Ointment

8.6.1        Overview

8.6.2        Ointment Market Revenue and Forecasts to 2028 (US$ Million)

9.          Asia Pacific Ocular Drug Delivery Market Analysis – By Disease Type

9.1        Overview

9.2        Asia Pacific Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

9.3        Cataract

9.3.1        Overview

9.3.2        Cataract Market Revenue and Forecast to 2028 (US$ Million)

9.4        Dry Eye Syndrome

9.4.1        Overview

9.4.2        Dry Eye Syndrome Market Revenue and Forecast to 2028 (US$ Million)

9.5        Macular Degeneration

9.5.1        Overview

9.5.2        Macular Degeneration Market Revenue and Forecast to 2028 (US$ Million)

9.6        Glaucoma

9.6.1        Overview

9.6.2        Glaucoma Market Revenue and Forecast to 2028 (US$ Million)

9.7        Diabetic Retinopathy

9.7.1        Overview

9.7.2        Diabetic Retinopathy Market Revenue and Forecast to 2028 (US$ Million)

9.8        Diabetic Macular Edema

9.8.1        Overview

9.8.2        Diabetic Macular Edema Market Revenue and Forecast to 2028 (US$ Million)

9.9        Others

9.9.1        Overview

9.9.2        Others Market Revenue and Forecast to 2028 (US$ Million)

10.       Asia Pacific Ocular Drug Delivery Market Analysis – By End User

10.1      Overview

10.2      Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

10.3      Hospitals

10.3.1     Overview

10.3.2     Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.4      Ophthalmic Clinics

10.4.1     Overview

10.4.2     Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

10.5      Ambulatory Surgical Centers

10.5.1     Overview

10.5.2     Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

11.       Asia Pacific Ocular Drug Delivery Market – Country Analysis

11.1      Overview

11.1.1     Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

11.1.1.1       China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.1       China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.1.2       China: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.1.3       China: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.1.4       China: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.1.5       China: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

11.1.1.2       Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.1       Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.2.2       Japan: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.2.3       Japan: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.2.4       Japan: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.2.5       Japan: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

11.1.1.3       India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.1       India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.3.2       India: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.3.3       India: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.3.4       India: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.3.5       India: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

11.1.1.4       Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.4.1       Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.4.2       Australia: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.4.3       Australia: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.4.4       Australia: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.4.5       Australia: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

11.1.1.5       South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.5.1       South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.5.2       South Korea: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.5.3       South Korea: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.5.4       South Korea: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.5.5       South Korea: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

11.1.1.6       Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.6.1       Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

11.1.1.6.2       Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology, 2019–2028 (USD Million)

11.1.1.6.3       Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type, 2019–2028 (USD Million)

11.1.1.6.4       Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type, 2019–2028 (USD Million)

11.1.1.6.5       Rest of Asia Pacific: Ocular Drug Delivery Market, by End User, 2019–2028 (USD Million)

12.       Impact Of COVID-19 Pandemic on Asia Pacific Ocular Drug Delivery Market

12.1      Impact Assessment of COVID-19 Pandemic

13.       Industry Landscape

13.1      Overview

13.2      Organic Developments

13.2.1     Overview

13.3      Inorganic Developments

13.3.1     Overview

14.       Company Profiles

14.1      AbbVie Inc.

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2      Bausch Health Companies Inc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3      Taiwan Liposome Company, Ltd.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4      Novartis AG

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5      Clearside Biomedical, Inc.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

15.       Appendix

15.1      About The Insight Partners

15.2      Glossary of Terms

LIST OF TABLES

Table 1.            China: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 2.            China: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 3.            China: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 4.            China: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5.            Japan: Ocular Drug Delivery Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 6.            Japan: Ocular Drug Delivery Market, By Formulation Type– Revenue and Forecast to 2028 (USD Million)

Table 7.            Japan: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 8.            Japan: Ocular Drug Delivery Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.            India: Ocular Drug Delivery Market, By Technology– Revenue and Forecast to 2028 (USD Million)

Table 10.          India: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 11.          India: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 12.          India: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13.          Australia: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 14.          Australia: Ocular Drug Delivery Market, By Formulation Type– Revenue and Forecast to 2028 (USD Million)

Table 15.          Australia: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 16.          Australia: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17.          South Korea: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 18.          South Korea: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 19.          South Korea: Ocular Drug Delivery Market, by Disease Type – Revenue and Forecast to 2028 (USD Million)

Table 20.          South Korea: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of Asia Pacific: Ocular Drug Delivery Market, By Technology – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of Asia Pacific: Ocular Drug Delivery Market, By Formulation Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Asia Pacific: Ocular Drug Delivery Market, by Disease Type– Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of Asia Pacific: Ocular Drug Delivery Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 25.          Organic Developments Done By Companies

Table 26.          Inorganic Developments Done by Companies

Table 27.          Glossary of Terms, Ocular Drug Delivery Market

LIST OF FIGURES

Figure 1.           Asia Pacific Ocular Drug Delivery Market Segmentation

Figure 2.           Asia Pacific Ocular Drug Delivery Market Segmentation, By Country

Figure 3.           Asia Pacific Ocular Drug Delivery Market Overview

Figure 4.           Implantable Ocular Drug Delivery Systems Segment Held the Largest Share of the Technology Segment in Ocular Drug Delivery Market

Figure 5.           Japan to Show Significant Growth During Forecast Period

Figure 6.           Asia Pacific Ocular Drug Delivery Market, Industry Landscape

Figure 7.           Asia Pacific PEST Analysis

Figure 8.           Ocular Drug Delivery Market Impact Analysis of Driver and Restraints

Figure 9.           Asia Pacific Ocular Drug Delivery Market – Revenue Forecast and Analysis – 2020- 2028

Figure 10.        Asia Pacific Ocular Drug Delivery Market Share by Technology 2021 & 2028 (%)

Figure 11.        Implantable Ocular Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Particulate Drug Delivery Systems Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Nano-Particle Drug Delivery System Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Asia Pacific Ocular Drug Delivery Market, By Formulation Type 2021 & 2028 (%)

Figure 16.        Liposomes and Nanoparticles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Solution Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Emulsion Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Suspension Market Revenue and Forecasts to 2028 (US$ Million)

Figure 20.        Ointment Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Asia Pacific Ocular Drug Delivery Market Share by Disease Type 2021 & 2028 (%)

Figure 22.        Cataract Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Dry Eye Syndrome Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Macular Degeneration Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25.        Glaucoma Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26.        Diabetic Retinopathy Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27.        Diabetic Macular Edema Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        Others Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        Ocular Drug Delivery Market Share, by End User, 2021 and 2028 (%)

Figure 30.        Hospitals: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Ophthalmic Clinics: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 32.        Ambulatory Surgical Centers: Ocular Drug Delivery Market– Revenue and Forecast to 2028 (US$ Thousand)

Figure 33.        Asia Pacific: Ocular Drug Delivery Market, by Key Country – Revenue (2021) (USD Million)

Figure 34.        Asia Pacific: Ocular Drug Delivery Market, by Country, 2021 & 2028 (%)

Figure 35.        China: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 36.        Japan: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 37.        India: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 38.        Australia: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 39.        South Korea: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 40.        Rest of Asia Pacific: Ocular Drug Delivery Market – Revenue and Forecast to 2028 (USD Million)

Figure 41.        Impact of COVID-19 Pandemic in Asia Pacific Country Markets

  1. AbbVie Inc.                                              
  2. Bausch Health Companies Inc.            
  3. Novartis AG                                            
  4. Clearside Biomedical, Inc.
  5. Taiwan Liposome Company, Ltd.        
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific ocular drug delivery market
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific ocular drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the ocular drug delivery market as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an.. May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec.. May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription